
Loading, please wait...

Loading, please wait...

Recent large-scale epidemiological investigations provide critical insights into childhood neurological disorders and perinatal outcomes among diverse maternal populations. Specifically, evaluating cerebral palsy prevalence alongside perinatal mortality rates reveals unexpected clinical patterns across native and immigrant demographic groups. Clinicians and researchers frequently anticipate higher rates of neurological impairment among vulnerable populations due to systemic barriers, unequal healthcare access, and known biological risk profiles. However, comprehensive data from national health registries demonstrate a nuanced reality. These findings emphasize that maternal country of origin, sociodemographic factors, and antenatal exposures interact in complex ways to influence fetal and neonatal survival. Consequently, obstetricians, pediatricians, and neonatologists must examine these relationships closely to enhance maternal-fetal management and improve long-term pediatric neurodevelopmental surveillance.
A nationwide registry-based cross-sectional study linking the Medical Birth Registry of Norway to the Norwegian Quality and Surveillance Registry for Cerebral Palsy analyzed births spanning from 2000 to 2016. Researchers categorized maternal country of birth into three distinct groups: non-immigrant mothers born in Norway, immigrant mothers from high-income countries, and immigrant mothers from low- and middle-income countries. The investigation examined verified clinical diagnoses alongside comprehensive perinatal data. Interestingly, the birth prevalence of cerebral palsy among children of non-immigrant mothers reached 2.11 per 1000 live births. In contrast, children born to mothers from high-income countries exhibited a prevalence of 1.44 per 1000 live births, while children of mothers originating from low- and middle-income countries demonstrated a prevalence of 1.71 per 1000 live births.
Furthermore, logistic regression modeling revealed that the unadjusted odds ratio for cerebral palsy was 0.68 for mothers from high-income countries and 0.81 for mothers from low- and middle-income countries relative to non-immigrant mothers. Therefore, offspring of immigrant mothers demonstrated statistically lower odds of diagnosed cerebral palsy compared to native peers. This epidemiological trend persisted even after controlling for established clinical risk factors. Consequently, these findings challenge standard clinical assumptions regarding neurodevelopmental morbidity in migrant populations.
To contextualize these findings, investigators carefully evaluated maternal and neonatal risk factors that traditionally correlate with cerebral palsy. The analysis revealed marked variations in baseline clinical characteristics across maternal cohorts. For instance, mothers migrating from low- and middle-income countries exhibited significantly higher rates of consanguinity compared to non-immigrant peers. Additionally, these mothers reported substantially lower periconceptional folic acid supplementation, which represents a critical preventative intervention for early embryonic neural development.
Moreover, infants born to mothers from low- and middle-income countries more frequently presented with lower Apgar scores at birth, reflecting increased immediate perinatal physiological distress. Nevertheless, despite the presence of these well-documented risk factors, multivariable logistic regression demonstrated that adjusting for parental consanguinity, folate intake, and low Apgar scores did not alter the lower odds ratios for cerebral palsy. Thus, conventional risk modeling fails to explain why children born to immigrant mothers from lower-resource regions do not display higher rates of cerebral palsy at birth. This persistent statistical pattern prompts deeper investigation into underlying survival mechanisms and antenatal selection phenomena.
The primary clinical explanation for the unexpectedly lower birth prevalence of cerebral palsy centers on competitive perinatal survival. While live-born children of immigrant mothers from lower-income countries showed lower rates of cerebral palsy, this population experienced significantly higher perinatal mortality. Specifically, perinatal death rates were substantially elevated among offspring of mothers from low- and middle-income countries compared to native Norwegian mothers. Therefore, severe intrauterine or intrapartum insults that might otherwise lead to survival with cerebral palsy may instead result in perinatal demise in this cohort.
In contrast, healthcare systems with advanced neonatal intensive care often successfully rescue extremely fragile neonates with severe brain injuries, allowing them to survive with permanent motor deficits. If severely compromised fetuses or neonates from migrant backgrounds face higher mortality during the late gestational and immediate neonatal periods, the resulting pool of surviving live-born infants naturally exhibits a lower apparent frequency of motor disabilities. Consequently, clinicians must interpret cerebral palsy statistics alongside fetal and early neonatal survival metrics. Recognizing this survival paradox prevents healthcare providers from misinterpreting lower disease prevalence as superior underlying neurodevelopmental protection.
Beyond motor impairment prevalence, analyzing phenotypic severity provides crucial clinical insights. The registry data demonstrated notable differences in clinical characteristics among children who received a confirmed cerebral palsy diagnosis. Specifically, children born to mothers from low- and middle-income countries presented with significantly higher proportions of concurrent intellectual disability compared to children of non-immigrant mothers. Thus, while fewer children from this demographic survived with cerebral palsy, those who did survive exhibited greater overall neurodevelopmental impairment.
Furthermore, this observation aligns with the biological severity hypothesis. High-energy metabolic crises, severe asphyxia, and severe antenatal infections often produce widespread cerebral injury affecting both motor tracts and cortical structures. Additionally, cultural, linguistic, and socioeconomic barriers may delay early diagnostic evaluations, leading to ascertainment bias where only the most severe, multi-domain presentations receive timely clinical documentation. Consequently, multidisciplinary pediatric teams must maintain rigorous surveillance protocols. Clinicians should ensure that mild or moderate motor deficits in migrant children receive early identification and therapeutic support before secondary developmental delays emerge.
These findings carry direct implications for modern perinatal, neonatal, and pediatric care teams. Obstetricians and maternal-fetal medicine specialists must prioritize culturally tailored antenatal education, focusing on early periconceptional folate intake, gestational diabetes screening, and consistent fetal monitoring. Addressing communication barriers and sociodemographic disadvantages during routine prenatal visits can directly reduce preventable perinatal mortality and severe fetal distress.
Similarly, neonatologists and pediatric care teams must implement standardized neurodevelopmental follow-up programs for all high-risk infants, regardless of maternal background. Clinicians must not assume that immigrant status confers lower risk simply because overall population prevalence appears reduced. Instead, healthcare systems should provide targeted developmental screenings, physical therapy referrals, and cognitive assessments to mitigate compounding disparities. By bridging clinical vigilance with equitable perinatal access, clinicians can optimize survival while simultaneously minimizing long-term neurodisability.
Children of immigrant mothers from low- and middle-income countries exhibited lower rates largely due to higher perinatal mortality. Severe fetal and neonatal insults often resulted in perinatal death rather than survival with chronic neurological impairment, thereby reducing the total proportion of live-born children diagnosed with cerebral palsy.
Elevated perinatal mortality creates a survival paradox by removing the most severely affected fetuses and neonates from the surviving cohort. Consequently, live-birth prevalence statistics alone can mask true underlying vulnerabilities, requiring clinicians to analyze perinatal mortality alongside long-term neurodevelopmental outcomes for accurate risk assessment.
Clinicians should implement culturally sensitive prenatal care, emphasize early periconceptional folic acid supplementation, enhance fetal monitoring, and address language barriers. Furthermore, standardizing neonatal follow-up protocols ensures timely identification of motor delays, intellectual disabilities, and associated neurodevelopmental deficits in high-risk pediatric populations.
Disclaimer: This content is for informational and educational purposes only and is not intended to substitute professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Do not disregard or delay seeking medical advice because of information presented here. Refer to the latest local and national guidelines for clinical practice.
References
Sigholt MW et al. Cerebral palsy and perinatal mortality in children born in Norway to immigrant mothers. Dev Med Child Neurol. 2025 Aug. doi: 10.1111/dmcn.16253. PMID: 39887728.
Glinianaia SV, Rankin J, Colver A. Cerebral palsy by socioeconomic status and maternal country of birth: a systematic review. Dev Med Child Neurol. 2017;59(7):688-698.
Hollung SJ, Vik T, Lydersen S, et al. Decreasing prevalence and severity of cerebral palsy in Norway among children born 1999 to 2014. Eur J Paediatr Neurol. 2020;28:162-171.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive Norwegian registry study examines cerebral palsy prevalence and perinatal mortality across immigrant cohorts, revealing critical insights into maternal risk factors, fetal survival dynamics, and neurodevelopmental impairment severity.
Today

Mass spectrometry-based proteomics is transforming kidney disease management by identifying novel biomarkers, uncovering pathogenic pathways, and paving the way for precision nephrology through multiomics and artificial intelligence integration.
Today

A comprehensive review of the genetics in heterotaxy, examining key pathogenic variants in DNAH9, PKD1L1, MMP21, and GDF1, genotype-phenotype correlations, and the role of trio WES/WGS in prenatal cardiology.
Today

Chitosan nanoparticles offer a breakthrough nanomedicine platform to mitigate ischemia-reperfusion injury across cardiac, cerebral, renal, and hepatic tissues by targeting oxidative stress, mitochondrial collapse, and acute inflammation.
Today

A retrospective cohort study reveals that patient body mass index significantly modifies the efficacy of Hemovac drainage on blood loss after total knee arthroplasty, supporting an individualized approach to drain placement alongside tranexamic acid.
Today

A new prospective study protocol examines the long-term impact of gender-affirming top surgery on mental health, gender dysphoria, chest congruence, and quality of life in transgender and nonbinary individuals.
Yesterday